NCT02603549

Brief Summary

Previous research has identified spontaneous cerebral spinal fluid leakage as a cause for spontaneous intracranial hypotension, leading to positional headache patterns. Typical magnetic resonance imaging findings include subdural fluid collections, enhancement of pachymenginges, engorgement of venous structures, pituitary hyperemia, and sagging of the brain (SEEPS). Because pituitary hyperemia has been documented in cases of spontaneous cerebral spinal fluid leakage and is known to mimic a pituitary tumor or hyperplasia, the investigators would like to like to assess the clinical manifestations and neuroimaging abnormalities of SIH patients with regard to the pituitary gland. Specifically, the investigators are looking to analyze the compression of the pituitary stalk and conduct a systemic evaluation of pituitary function in SIH patients.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 13, 2015

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

January 31, 2019

Status Verified

January 1, 2019

Enrollment Period

5.4 years

First QC Date

November 10, 2015

Last Update Submit

January 29, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparing the levels of prolactin pre and post treatment

    90 days

Study Arms (1)

Surgery or Blood Patch

Other: Pituitary panel will be drawn pre-op and post-op for all patients.

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Spontaneous intracranial hypotension (SIH)

You may qualify if:

  • Male or female patients
  • Age 18 years and older
  • Diagnosis of SIH:
  • Brain MRI (SEEPS)

You may not qualify if:

  • Pregnant and post-partum females
  • Nursing mothers
  • Patients with potential hyperprolactinemia due to:
  • Hypothyroidism,
  • Chronic renal disorder
  • Liver disease (including cirrhosis)
  • Primary or secondary amenorrhea
  • Polycystic Ovary Syndrome
  • Seizure disorder
  • Illicit drug use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States

Location

Related Publications (3)

  • Schievink WI. Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. JAMA. 2006 May 17;295(19):2286-96. doi: 10.1001/jama.295.19.2286.

    PMID: 16705110BACKGROUND
  • SCHALTENBRAND G. Normal and pathological physiology of the cerebrospinal fluid circulation. Lancet. 1953 Apr 25;1(6765):805-8. doi: 10.1016/s0140-6736(53)91948-5. No abstract available.

    PMID: 13036182BACKGROUND
  • Mokri B. Cerebrospinal fluid volume depletion and its emerging clinical/imaging syndromes. Neurosurg Focus. 2000 Jul 15;9(1):e6. doi: 10.3171/foc.2000.9.1.6.

    PMID: 16859267BACKGROUND

MeSH Terms

Conditions

HyperprolactinemiaIntracranial Hypotension

Condition Hierarchy (Ancestors)

HyperpituitarismPituitary DiseasesHypothalamic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEndocrine System Diseases

Study Officials

  • Vivien Bonert, MD

    Cedars-Sinai Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Director, Pituitary Center

Study Record Dates

First Submitted

November 10, 2015

First Posted

November 13, 2015

Study Start

July 1, 2015

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

January 31, 2019

Record last verified: 2019-01

Locations